Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant

Bone Marrow Transplantation

Volumn 39, Issue 12, 2007, Pages 783-787

  Savona, M R ^a   Newton, D ^a   Frame, D ^b   Levine, J E ^a   Mineishi, S ^a   Kaul, D R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CARMUSTINE; CIDOFOVIR; CREATININE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUDARABINE; MEPREDNISONE; PROBENECID; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BK VIRUS; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG RESPONSE; DRUG SAFETY; FEMALE; GRAFT VERSUS HOST REACTION; HEMORRHAGIC CYSTITIS; HODGKIN DISEASE; HUMAN; IRRADIATION; KIDNEY DYSFUNCTION; LOW DRUG DOSE; MALE; MICROBIOLOGICAL EXAMINATION; MULTIPLE MYELOMA; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NEPHROTIC SYNDROME; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SIDE EFFECT; SYMPTOM; URINALYSIS; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; BK VIRUS; CYSTITIS; CYTOSINE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; PHOSPHONIC ACIDS; POLYOMAVIRUS INFECTIONS; TREATMENT OUTCOME; TUMOR VIRUS INFECTIONS;

EID: 34250219674     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705678     Document Type: Article

References (27)

1. Hirsch HH. BK virus: Opportunity makes a pathogen. Clin Infect Dis 2005; 41: 354-360.
2. Arthur RR, Shah KV, Baust SJ, Santos GW, Saral R. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med 1986; 315: 230-234.
3. Cesaro S, Brugiolo A, Faraci M, Uderzo C, Rondelli R, Favre C et al. Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: A survey from the Italian association of pediatric hematology oncology-bone marrow transplantation group. Bone Marrow Transplant 2003; 32: 925-931.
4. Gonzalez-Fraile MI, Canizo C, Caballero D, Hernandez R, Vazquez L, Lopez C et al. Cidofovir treatment of human polyomavirus-associated acute haemorrhagic cystitis. Transpl Infect Dis 2001; 3: 44-46.
5. Gorczynska E, Turkiewicz D, Rybka K, Toporski J, Kalwak K, Dyla A et al. Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2005; 11: 797-804.
6. Leung AY, Suen CK, Lie AK, Liang RH, Yuen KY, Kwong YL. Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood 2001; 98: 1971-1978.
7. Leung AY, Chan MT, Yuen KY, Cheng VC, Chan KH, Wong CL et al. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2005; 40: 528-537.
8. Bogdanovic G, Priftakis P, Giraud G, Kuzniar M, Ferraldeschi R, Kokhaei P et al. Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation. J Clin Microbiol 2004; 42: 5394-5396.
9. Azzi A, Cesaro S, Laszlo D, Zakrzewska K, Ciappi S, De Santis R et al. Human polyoma virus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients. J Clin Virol 1999; 14: 79-86.
10. Erard V, Kim HW, Corey L, Limaye A, Huang ML, Myerson D et al. BK DNA viral load in plasma: Evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients. Blood 2005; 106: 1130-1132.
11. De Clercq E. In search of a selective antiviral chemotherapy. Clin Microbiol Rev 1997; 10: 674-693.
12. Andrei G, Snoeck R, Vandeputte M, De Clercq E. Activities of various compounds against murine and primate polyomaviruses. Antimicrob Agents Chemother 1997; 41: 587-593.
13. Kuypers DR, Vandooren AK, Lerut E, Evenepoel P, Claes K, Snoeck R et al. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am J Transplant 2005; 5: 1997-2004.
14. Ramos E, Drachenberg CB, Portocarrero M, Wali R, Klassen DK, Fink JC et al. BK virus nephropathy diagnosis and treatment: Experience at the University of Maryland Renal Transplant Program. Clin Transpl 2002, 143-153.
15. Tong CY, Hilton R, MacMahon EM, Brown L, Pantelidis P, Chrystie IL et al. Monitoring the progress of BK virus associated nephropathy in renal transplant recipients. Nephrol Dial Transplant 2004; 19 2598-2605.
16. Vats A, Shapiro R, Randhawa P, Scantlebury V, Tuzuner A, Saxena M et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 2003; 75: 106-112.
17. Hatakeyama N, Suzuki N, Kudoh T, Hori T, Mizue N, Tsutsumi H. Successful cidofovir treatment of adenovirus-associated hemorrhagic cystitis and renal dysfunction after allogenic bone marrow transplant. Pediatr Infect Dis J 2003; 22: 928-929.
18. Palandri F, Bonifazi F, Rossi C, Falcioni S, Arpinati M, Giannini MB et al. Successful treatment of severe hemorrhagic cystitis with selective vesical artery embolization. Bone Marrow Transplant 2005; 35: 529-530.
19. Held TK, Biel SS, Nitsche A, Kurth A, Chen S, Gelderblom HR et al. Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir. Bone Marrow Transplant 2000; 26: 347-350.
20. Bedi A, Miller CB, Hanson JL, Goodman S, Ambinder RF, Charache P et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995; 13: 1103-1109.
21. Cundy K, Petty B, Flaherty J, Fisher P, Polis M, Wachsman M et al. Clinical pharmacokinetics of cidofovir in HIV infected patients. Antimicrob Agents Chemother 1995; 39: 1247-1252.
22. Lalezari J, Drew W, Glutzer E, James C, Miner D, Flaherty J et al. HPMPC: Results of a phase I/II study of a novel nucleotide analogue. J Infect D 1995; 171: 788-796.
23. Lalezari J, Stagg R, Kupperman B, Holland G, Kramer F, Ives D et al. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. Ann Intern Med 1997; 126: 257-263.
24. Wachsman M, Petty B, Cundy K, Jaffe H, Fisher P, Pastelak A et al. Pharmacokinetics, safety, and bioavailability of cidofovir in HIV infected subjects. Antiviral Res 1996; 29: 153-161.
25. Wolf D, Rodriquez C, Mucci M, Ingrosso A, Duncan B, Nickens D. Pharmacokinetics and renal effects of cidofovir with reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis. J Clin Pharmacol 2003; 43: 43-51.
26. Bridges B, Donegan S, Badros A. Cidofovir bladder instillation for the treatment of BK hemorrhagic cystitis after allogeneic stem cell transplantation. Am J Hematol 2006; 81: 535-537.
27. Fanourgiakis P, Georgala A, Vekemans M, Triffet A, De Bruyn JM, Duchateau V et al. Intravesical instillation of cidofovir in the treatment of hemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipient. Clin Infect Dis 2005; 40: 199-201.